Polyfunctional CD4 + and CD8 + T cell responses are elicited against the SARS-CoV-2 spike protein after two doses of the AZD1222 COVID-19 vaccine.
Journal article
Science Translational Medicine
American Association for the Advancement of Science (AAAS)
17/11/2021
13